Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Second Look Laparoscopy in Colorectal Cancer [Phase 2]
Phase 2 clinical trial update for second-look laparoscopy in colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating preoperative valproic acid in combination with radiation therapy for colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2023-03-24Clinical Trial Update: A Phase 2 Study of Panitumumab in Patients With Cetuximab-refractory Metastatic Colorectal Cancer [Phase 2]
Phase 2 study investigating panitumumab in patients with cetuximab-refractory metastatic colorectal cancer is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-03-23Clinical Trial Update: Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer [Phase 2]
Phase 2 clinical trial evaluating regorafenib plus a PD-1 antibody with radiotherapy for metastatic colorectal cancer that is microsatellite…
-
CLINICAL_TRIALS trial_result · 2023-03-22Clinical Trial Update: A Phase I/II Study With BM7PE Immunotoxin in Colorectal Cancer Patients [Phase 1, Phase 2]
Phase I/II study update on BM7PE immunotoxin in metastatic colorectal cancer; current status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers [Phase 2]
Phase 2 trial of perioperative MVT-5873, a CA 19-9 epitope–targeting monoclonal antibody, in operable CA 19-9–producing pancreatic cancers, …
-
CLINICAL_TRIALS trial_result · 2023-03-20Clinical Trial Update: Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases [Phase 2]
A Phase 2 clinical trial update investigating a quintuple treatment method for patients with colorectal liver metastases who cannot undergo …
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: Sintilimab (IBI308) Combined With Bevacizumab + XELOX Regimen in Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial evaluating Sintilimab combined with Bevacizumab and XELOX in metastatic colorectal cancer with RAS mutation (MSI-stable).
-
CLINICAL_TRIALS trial_result · 2023-03-17Clinical Trial Update: Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia [Phase 4]
Phase 4 trial evaluating whether perioperative nutrition with insulin can enhance anabolic effects while maintaining normoglycemia in colore…
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation [Phase 2]
Phase 2 trial investigating liver transplantation to improve outcomes in selected patients with non-resectable hepatic metastases from color…
-
CLINICAL_TRIALS withdrawal · 2023-03-15Clinical Trial Update: Effect of Probiotics Supplementation on the Side Effects of Radiation Therapy Among Colorectal Cancer Patients [Phase 2, Phase 3]
A clinical trial investigating probiotics to mitigate radiation side effects in colorectal cancer patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-03-14Clinical Trial Update: Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC [Phase 3]
A Phase 3 trial comparing chidamide+syntilimab+bevacizumab versus standard second-line FOLFIRI+bevacizumab in metastatic microsatellite-stab…
-
CLINICAL_TRIALS trial_result · 2023-03-08Clinical Trial Update: REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]
Phase 1/2 trial REVEAL exploring NKTR-262 with NKTR-214 and nivolumab in various locally advanced/metastatic solid tumors was terminated; re…
-
CLINICAL_TRIALS trial_result · 2023-03-06Clinical Trial Update: Hyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial [Phase 2]
Phase II clinical trial evaluating hyperthermic intraperitoneal treatment with rmhTNF for colorectal cancer with peritoneal metastases.
-
CLINICAL_TRIALS trial_result · 2023-03-03Clinical Trial Update: A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors [Phase 1, Phase 2]
A Phase I/II study investigating regorafenib in combination with avelumab in various solid tumors, spanning Phase 1 and Phase 2 cohorts.
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: mFOLFOX6 Combined With Dalpiciclib in Patients With Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial evaluating mFOLFOX6 plus dalpiciclib in advanced/metastatic colorectal cancer is in progress with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors [Phase 1]
Phase 1 trial update on an arginase-1 peptide vaccine in patients with metastatic solid tumors, including non-small cell lung cancer and uro…
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: The Efficacy and Safety of Fluzoparib Plus Irinotecan as Second-line Treatment in Patients With Homologous Recombination Deficiency (HRD) Metastatic Colorectal Cancer. [Phase 2]
Phase 2 trial updating the efficacy and safety of fluzoparib plus irinotecan as second-line therapy in metastatic colorectal cancer with hom…
-
CLINICAL_TRIALS trial_result · 2023-02-24Clinical Trial Update: Pembrolizumab and Olaparib in Homologous-recombination Deficient (HRD) Advanced Colorectal Cancer (CRC). [Phase 2]
Phase 2 trial evaluating pembrolizumab plus olaparib in HRD-deficient metastatic colorectal cancer is in early results with status currently…
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM [Phase 3]
Phase 3 trial comparing FUDR/Oxaliplatin hepatic arterial infusion plus Irinotecan versus FOLFOXIRI chemotherapy in initially unresectable c…
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: A Study of ES104 in Patients With Metastatic Colorectal Cancer [Phase 1, Phase 2]
Clinical trial update for ES104 in metastatic colorectal cancer across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: Re-challenge of Anti-EGFR for Patients With RAS/BRAF Wild-type Metastatic CRC [Phase 2]
Phase 2 clinical trial update on re-challenge of anti-EGFR therapy in patients with RAS/BRAF wild-type metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer [Phase 1, Phase 2]
Clinical trial updates the efficacy of the VIC regimen in metastatic colorectal cancer (BRAF-mutant) across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM [Phase 2]
Phase 2 trial evaluating systemic chemotherapy CPT-11 with hepatic arterial infusion FUDR+L-OHP for initially unresectable colorectal cancer…
-
CLINICAL_TRIALS trial_result · 2023-02-14Clinical Trial Update: mFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal Cancer [Phase 3]
A Phase 3 trial evaluating mFOLFOX6 chemotherapy combined with apatinib as postoperative treatment in high-risk colorectal cancer (Stage III…